🕯️🕯️ ነፍስ ይማር !🙏

"በዛሬው ዕለት ማለትም ( ሐሙስ  12/6/2018ዓ.ም) በድንገት ያጣነውን ውድ ወንድማችንን ዶ/ር በውቀቱ አንዳርጌን ለመዘከር የኮሌጃችን የስራ ሀላፊዎች፣ሀኪሞች እና ተማሪዎች የሚገኙበት  የሻማ ማብራት እና የጸሎት  መርሐግብር ይዘጋጃል።

ስለሆነም እናንተ ውድ የህክምናና ጤና ሳይንስ ኮሌጅ ተማሪዎች እንዲሁም የኮሌጁ ማኀበረሰብ በሙሉ በፕሮግራሙ  ተገኝታችሁ በጋራ ሆነን ውድ ወንድማችንን በጸሎት እናስበው ዘንድ ጠርተናችኋል ።"የክፍል ጓደኞቹ

ቦታ፡Lecture Hall around registrar office
ሰዓት፡ ምሽት 1፡00-2:00 ሰዓት

Your mental health matters just as much as physical health! Take a break, breathe deeply, and check in with yourself today. Remember: it's okay to ask for help. Let's support each other! How do you prioritize your mental well-being? #youarenotalone❤️

Dr.Tedros Adhanom , WHO Director General
©https://www.facebook.com/share/1BvoT3YHoL/

Night in Copenhagen

Over the past year, I have been following Denmark’s remarkable economic surge driven to a striking degree by one company and one therapeutic class: GLP-1 receptor agonists.

The expansion of Novo Nordisk is estimated to have added around 1.8 percentage points to Denmark’s GDP growth since 2023. Without it, the national economy might have faced stagnation, even contraction.

Few medicines in history have shifted a country’s macroeconomic trajectory so visibly.

For health professionals, this is more than a pharmaceutical success story. It demonstrates how biomedical innovation in metabolic diseases can influence exports, currency strength, labor markets, and national confidence.

Science is no longer just shaping clinical outcomes, it is reshaping economies.

Yet from the perspective of someone working on diseases of poverty, this success raises uncomfortable questions. When one therapeutic area can move GDP, capital naturally flows toward what is most profitable. What then happens to tropical and infectious diseases that do not command high-income markets?

Innovation is powerful but it is not neutral. Health, science, and economics are deeply interconnected, and unless we rebalance incentives, the gap between blockbuster therapies and neglected diseases may continue to widen.

518 ሰዎች (የህክምና ተማሪዎች እና ሀኪሞች) ምን መለሱ?

Top Stressors:

1️⃣ FOMO & “Shortcut Success” Culture (Contents) – 39%
Luxury lifestyles on social media and fast-money narratives are the biggest trigger, questioning long-term sacrifice.

2️⃣ Unrealistic Family/Community Expectations – 37%
External pressure is almost equal to FOMO.

3️⃣ Negative Narrative About Ethio_Medical Life On Social Media– 36%
Constant exposure to only the bad side of medicine affects morale. Repeated negativity reshapes identity. We all should balance what we post on social media.

4️⃣ Political/Ethnic Polarization – 31%

5️⃣ Guilt from Time Spent Scrolling – 30%

6️⃣ Academic Comparison – 27%
Interestingly lower than financial/lifestyle pressure.
That tells us something: economic visibility may now weigh heavier than exam competition.

What This Poll Really Shows?
This isn’t about weak individuals. It’s about a high-pressure profession living inside a high-visibility digital culture.Medicine is slow growth. Social media rewards speed and display. That mismatch creates tension.

For Medical Social Media Channels
Yes, we must speak about: System problems, Burnout , Salary realities.But if we amplify only struggle, we unintentionally deepen hopelessness.

Balanced storytelling matters:
☀️Show real challenges
☀️Show real solutions
☀️Highlight doctors building meaningful impact locally
☀️Normalize slow success
☀️Encourage grounded ambition, not comparison

@debolteam